Schedule 13G ownership disclosure

Arcutis Biotherapeutics Inc

Security class unavailable · CUSIP: 03969K108

Event date: 2023-10-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-23-005865
Form type
SC 13G
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Oct 30, 2023
Reporting period
Oct 20, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub